Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.00%116.91B | -15.85%98.88B | -9.22%83.29B | -3.44%424.23B | -22.06%101.47B | 78.95%113.51B | -6.41%117.51B | -23.64%91.75B | 87.65%439.34B | 40.69%130.19B |
| Total premiums earned | 1.77%22.45B | 1.10%22.2B | 1.54%21.8B | 5.82%88.26B | 5.02%22.78B | 3.25%22.06B | 6.77%21.95B | 8.48%21.47B | 11.84%83.4B | 7.08%21.69B |
| Net investment income | 10.26%20.56B | -55.99%7.59B | -270.14%-6.78B | -28.70%49.3B | -88.17%4.24B | 161.42%18.64B | -47.79%17.25B | -87.28%3.98B | 209.54%69.14B | 103.28%35.88B |
| Net realized gain loss on investments | -26.03%1.38B | -118.61%-1.23B | 116.14%340M | -38.68%3.5B | 146.32%2.31B | 224.83%1.87B | 43,933.33%6.61B | -161.20%-2.11B | 219.50%5.71B | 129.41%937M |
| Fee revenue and other income | 2.80%66.83B | -3.16%64.32B | -2.76%62.29B | -1.49%261.35B | -1.76%65.87B | -4.12%65.01B | -2.47%66.42B | 2.71%64.06B | 22.16%265.32B | 22.67%67.05B |
| -Fees and commissions | 2.93%52.29B | -4.34%50.97B | -4.46%48.69B | -2.18%207.25B | -42.64%52.2B | 24.39%50.8B | 31.19%53.29B | 29.33%50.97B | 30.11%211.88B | 122.54%91.02B |
| -Other income expense | 2.33%14.55B | 1.63%13.35B | 3.85%13.6B | 1.24%54.1B | 157.01%13.66B | -47.29%14.21B | -52.22%13.13B | -42.98%13.09B | -1.66%53.44B | -274.20%-23.97B |
| Interest income | -3.90%5.7B | 13.59%6B | 29.83%5.63B | 38.45%21.83B | 35.18%6.28B | 46.48%5.93B | 37.39%5.28B | 34.34%4.34B | 53.60%15.76B | 46.81%4.64B |
| Total expenses | -2.71%78.81B | 5.99%84.13B | 2.77%78.14B | -1.67%313.86B | -6.98%77.44B | 0.76%81B | -0.94%79.37B | 0.85%76.04B | 20.61%319.17B | 18.21%83.25B |
| Loss adjustment expense | -7.69%14.85B | 0.96%15.21B | 9.18%15.71B | -1.91%60.04B | -10.09%14.5B | 8.24%16.09B | -1.03%15.06B | -4.09%14.39B | -2.66%61.22B | 0.93%16.13B |
| Fees and commission expense | 3.27%40.88B | -5.86%39.62B | -5.49%38.55B | -3.33%163.64B | -46.71%41.19B | 27.47%39.58B | 37.43%42.08B | 34.54%40.79B | 36.17%169.28B | 144.53%77.29B |
| Underwriting expenses | -10.19%4.43B | 10.13%4.46B | 16.39%4.37B | 10.07%16.81B | -8.59%4.08B | 41.13%4.93B | 8.50%4.05B | 4.63%3.75B | 30.45%15.27B | 8.41%4.46B |
| Selling general and administration | -18.32%8.16B | 26.33%9.82B | 32.30%9.57B | 3.86%32.71B | -32.01%7.71B | 51.20%9.99B | 20.27%7.77B | 2.16%7.23B | 25.70%31.5B | 28.53%11.35B |
| -General and administrative expense | -18.32%8.16B | 26.33%9.82B | 32.30%9.57B | 3.86%32.71B | -32.01%7.71B | 51.20%9.99B | 20.27%7.77B | 2.16%7.23B | 25.70%31.5B | 28.53%11.35B |
| -Selling and marketing expense | ---- | ---- | ---- | 0.72%25.64B | -14.19%8.35B | 43.05%7.32B | 3.80%5.2B | -14.80%4.77B | 30.51%25.46B | 31.06%9.73B |
| Net non operatingInterest income (expenses) | -3.87%-1.26B | -1.87%-1.25B | 4.48%-1.26B | -3.94%-5.2B | -12.85%-1.44B | 3.65%-1.21B | 1.52%-1.23B | -8.05%-1.32B | -14.96%-5B | -12.03%-1.28B |
| -Interest expense-non operating | 3.87%1.26B | 1.87%1.25B | -4.48%1.26B | 3.94%5.2B | 12.85%1.44B | -3.65%1.21B | -1.52%1.23B | 8.05%1.32B | 14.96%5B | 12.03%1.28B |
| Income from associates and other participating interests | 48.65%330M | -1,982.94%-4.75B | -74.44%126M | -6.69%1.84B | 70.70%874M | -15.27%222M | -50.68%252M | -28.34%493M | 5.90%1.97B | -43.43%512M |
| Other Operating costs | 1.50%9.56B | -4.22%9.04B | -2.61%8.81B | -4.08%37.29B | 135.15%9.4B | -59.72%9.42B | -59.62%9.43B | -52.08%9.05B | 1.88%38.88B | -376.69%-26.74B |
| Income before tax | 17.22%38.11B | -61.32%14.75B | -67.22%5.15B | -8.15%110.38B | -48.82%24.03B | 291.69%32.51B | -16.06%38.14B | -64.90%15.71B | 493.99%120.17B | 112.30%46.94B |
| Income tax | 20.12%7.24B | -69.98%2.29B | -83.44%476M | -9.57%20.82B | -53.44%4.27B | 237.25%6.03B | -17.29%7.64B | -68.05%2.87B | 370.75%23.02B | 137.09%9.18B |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 16.56%30.86B | -59.15%12.46B | -63.59%4.67B | -7.81%89.56B | -47.69%19.75B | 310.71%26.48B | -15.75%30.5B | -64.11%12.83B | 541.62%97.15B | 107.04%37.76B |
| Net Income continuous operations | 16.56%30.86B | -59.15%12.46B | -63.59%4.67B | -7.81%89.56B | -47.69%19.75B | 310.71%26.48B | -15.75%30.5B | -64.11%12.83B | 541.62%97.15B | 107.04%37.76B |
| Noncontrolling interests | -70.31%68M | -42.00%87M | -46.92%69M | -38.74%566M | -69.02%57M | 14.50%229M | -47.74%150M | -48.62%130M | 21.42%924M | 17.20%184M |
| Net income attributable to the company | 17.31%30.8B | -59.24%12.37B | -63.76%4.6B | -7.51%89B | -47.59%19.69B | 305.62%26.25B | -15.49%30.35B | -64.22%12.7B | 522.79%96.22B | 107.82%37.57B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 17.31%30.8B | -59.24%12.37B | -63.76%4.6B | -7.51%89B | -47.59%19.69B | 305.62%26.25B | -15.49%30.35B | -64.22%12.7B | 522.79%96.22B | 107.82%37.57B |
| Diluted earnings per share | 17.19%0.7874 | -59.28%0.3163 | -63.74%0.1177 | -6.79%2.2761 | -47.31%0.5036 | 307.07%0.6719 | -14.74%0.7767 | -63.80%0.3245 | 528.63%2.442 | 111.75%0.9557 |
| Basic earnings per share | 17.19%0.7874 | -59.28%0.3163 | -63.74%0.1177 | -6.79%2.2761 | -47.31%0.5035 | 307.07%0.6719 | -14.74%0.7767 | -63.80%0.3245 | 528.63%2.442 | 111.75%0.9557 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.